NCT06798935View on ClinicalTrials.gov

Feasibility and Safety of Additional Injection of Autologous Platelet-rich Stroma to Surgical Treatment of Rectovaginal Fistulas

PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

January 11, 2019

Primary Completion Date

September 4, 2024

Study Completion Date

September 4, 2024

Conditions
Rectovaginal FistulaAnovaginal Fistula
Interventions
PROCEDURE

autologous platelet-rich stroma

Autologous platelet-rich stroma, which is the combined product of stromal vascular fraction and platelet-rich plasma

Trial Locations (1)

Unknown

Ijsselland Hospital, Capelle aan den IJssel

Sponsors
All Listed Sponsors
collaborator

IJsselland ziekenhuis

UNKNOWN

lead

Erasmus Medical Center

OTHER